David A. Hodgson
Keppel Street
London, ENG, United Kingdom
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 44 publications
Mucosal IgA to pre-fusion F protein predicts protection from RSV infection in a high burden setting.
Mucosal IgA to pre-fusion F protein predicts protection from RSV infection in a high burden setting.
Journal: Nature communications
Published: March 30, 2026
Kinetics of antibodies and risk of respiratory syncytial virus infection: a longitudinal cohort in Taizhou City, eastern China.
Journal: BMC medicine
Published: September 28, 2025
Maternal immunity drives age-related patterns of RSV disease.
Journal: Epidemics
Published: September 10, 2025
serojump: A Bayesian tool for inferring infection timing and antibody kinetics from longitudinal serological data.
Journal: medRxiv : the preprint server for health sciences
Published: March 17, 2025
serojump: A Bayesian tool for inferring infection timing and antibody kinetics from longitudinal serological data.
Journal: PLoS computational biology
Published: March 06, 2025
Antibody responses against influenza A decline with successive years of annual influenza vaccination: results from an Australian Healthcare Worker cohort.
Journal: Research square
Published: October 07, 2024
Correction to "Protecting infants against RSV disease: an impact and cost-effectiveness comparison of long-acting monoclonal antibodies and maternal vaccination" [The Lancet Regional Health - Europe 38 (2024) 100829].
Journal: The Lancet regional health. Europe
Published: September 23, 2024
Memory B cell proliferation drives differences in neutralising responses between ChAdOx1 and BNT162b2 SARS-CoV-2 vaccines.
Journal: Frontiers in immunology
Published: August 27, 2024
Compartmentalised mucosal and blood immunity to SARS-CoV-2 is associated with high seroprevalence before the Delta wave in Africa.
Journal: Communications medicine
Published: August 07, 2024
Memory B cell proliferation drives differences in neutralising responses between ChAdOx1 and BNT162b2 SARS-CoV-2 vaccines.
Journal: medRxiv : the preprint server for health sciences
Published: July 23, 2024
Last Updated: 09/26/2026